Statistics for TransMedics Group (id:6421 TMDX)
Valuation metrics
Market cap
2.97B
Enterprise value
3.30B
Trailing P/E (ttm)
95.01
Forward P/E
53.55
PEG ratio
53.55
Price/Sales (ttm)
7.39
Price/Book (mrq)
14.13
Enterprise Value/Revenue
8.23
Enterprise Value/EBITDA
64.54
Overview
Shares outstanding
33.56M
Float
32.55M
Shares short
8.43M
% Held by insiders
0.03%
% Held by institutions
1.11%
Average volume (10 days)
1.63M
Average volume (90 days)
Price summary
52-Week low
67.77
52-Week high
177.37
52-Week change
7.50%
Beta
2.07
50-Day moving average
127.92
200-Day moving average
122.41
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
8.14%
Operating margin
3.61%
Operational effectiveness
Return on assets
2.84%
Return on equity
19.40%
Income statement
Revenue (ttm)
12.16
Revenue per share (ttm)
12.16
Quarterly revenue growth (yoy)
Gross profit (ttm)
154.09M
EBITDA
64.28M
Net income to common (ttm)
32.64M
Diluted EPS (ttm)
0.93
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
330.09M
Total cash per share (mrq)
9.84
Total debt (mrq)
518.15M
Total Debt/Equity (mrq)
246.83
Current ratio (mrq)
820.10%
Book value per share (mrq)
6.26
Cash flow
Cash flow statement
37.44M
Levered free cash flow (LFCF)
-142,587,504.00